Cumberland Pharmaceuticals CPIX Operating Lease Liability Payments - 2025 (Lessee)

Operating Lease Liability Payments - 2025 (Lessee) at other companies

PTH

Pelthos Therapeutics Inc.PTHS

——

Rigel PharmaceuticalsRIGL

——

BridgeBio PharmaBBIO

——

RFL

Rafael Holdings, Inc.RFL

——

Mirum Pharmaceuticals, Inc.MIRM

——

West Pharmaceutical ServicesWST

——

Other financials

Income statement

See full

Revenue$9.1M-22.0%

Gross profit$7.2M-30.0%

Operating income-$3.1M-342%

Net income-$3.3M-362%

EPS (diluted)-$0.22-375%

Balance sheet

See full

Cash & equivalents$11.0M-27.1%

Total debt$4.8M-7.1%

Total equity$21.6M-24.5%

Total assets$71.0M+1.5%

Cash flow

See full

Operating cash flow$387.0K-90.1%

CapEx--100%

Free cash flow$387.0K-89.9%

Valuation

See full

Market cap$97.09M+138%

Enterprise value$90.91M+207%

P/S2.3×+1.3×

Profitability

See full

Gross margin82.9%-1.4pp

Operating margin-17.2%-125pp

Net margin-17.6%-103pp

FCF margin3.3%—

Returns & leverage

See full

Return on equity-29.4%-86.3pp

Debt / equity0.2×0.0×

Current ratio1×-0.3×

Where this comes from

Reported directly by Cumberland Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour.

The official record: Cumberland Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cumberland Pharmaceuticals's operating lease liability payments - 2025 (lessee).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cumberland Pharmaceuticals's operating lease liability payments - 2025 (lessee)?: Cumberland Pharmaceuticals (CPIX) reported operating lease liability payments - 2025 (lessee) of $667.05K in Q1 2026.
How has Cumberland Pharmaceuticals's operating lease liability payments - 2025 (lessee) changed year-over-year?: Cumberland Pharmaceuticals's operating lease liability payments - 2025 (lessee) increased by 2.5% year-over-year, from $650.77K to $667.05K.